资讯

CVS Caremark drops coverage of popular weight loss drug
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
Natera's 'Signatera' detects recurrence of cancer through a blood test
Natera CEO Steve Chapman discusses the evolution of the company over ten years and how the company helps cancer patients on ...
Expert reveals if it's time for investors to up their stock exposure
Citi Head of U.S. Equity Trading Strategy Stuart Kaiser discusses what investors should commit to on 'The Claman Countdown.' ...